• 1
    WHO—Executive board 2000, 107th Session, EB107/26.
  • 2
    McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;312: 8290.
  • 3
    Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000; 2:CD000065.
  • 4
    Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999;94: 869877.
  • 5
    Moutquin JM, Sherman D, Cohen H, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 2000;182: 11911199.
  • 6
    Romero R, Sibai BM, Sanchez-Ramos L, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000;182: 11731183.
  • 7
    Valenzuela GJ, Sanchez-Ramos L, Romero R, et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. Am J Obstet Gynecol 2000;182: 11841190.
  • 8
    Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29: 297301.
  • 9
    Finnstrom O, Olausson PO, Sedin G, et al. The Swedish national prospective study on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to level of care. Acta Paediatr 1997;86: 503511.